| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8298 | 
      | Human Intestinal Absorption | HIA+ | 0.9962 | 
      | Caco-2 Permeability | Caco2- | 0.5187 | 
      | P-glycoprotein Substrate | Substrate | 0.6670 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8783 | 
                                                     | Inhibitor | 0.7308 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7391 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7743 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8374 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8840 | 
      | CYP450 3A4 Substrate | Substrate | 0.5656 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.8503 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.7199 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.7115 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.8977 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.7497 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9360 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9522 | 
                                                                    | Non-inhibitor | 0.8890 | 
      | AMES Toxicity | AMES toxic | 0.9107 | 
      | Carcinogens | Non-carcinogens | 0.9385 | 
      | Fish Toxicity | High FHMT | 0.9951 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9919 | 
      | Honey Bee Toxicity | High HBT | 0.8870 | 
      | Biodegradation | Not ready biodegradable | 0.7509 | 
      | Acute Oral Toxicity | III | 0.6516 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5712 |